Anna Ferrari Selected Research

Anna Ferrari Research Topics

Disease

23	Migraine Disorders (Migraine) 04/2022 - 09/2005
20	Headache (Headaches) 11/2021 - 08/2004
15	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 12/2008
12	Neoplasms (Cancer) 12/2023 - 04/2009
9	Pain (Aches) 01/2022 - 08/2004
9	Prostatic Neoplasms (Prostate Cancer) 11/2020 - 04/2009
6	COVID-19 01/2024 - 12/2020
6	Leukemia 01/2023 - 07/2011
5	Inflammation (Inflammations) 11/2021 - 12/2006
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 08/2011
5	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021 - 11/2015
4	Secondary Headache Disorders 10/2021 - 08/2006
4	Headache Disorders (Headache Syndromes) 01/2018 - 08/2006
3	Pneumonia (Pneumonitis) 01/2024 - 01/2021
3	Migraine without Aura (Common Migraine) 11/2021 - 07/2010
2	Migraine with Aura (Familial Hemiplegic Migraine) 10/2021 - 07/2010
2	Infections 01/2021 - 03/2011
2	Epilepsy (Aura) 10/2020 - 01/2009
2	Neoplasm Metastasis (Metastasis) 01/2020 - 07/2017
2	Philadelphia Chromosome 01/2018 - 12/2008
2	Thyroid Diseases (Thyroid Disease) 12/2015 - 01/2012
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2014 - 12/2004
2	Fibrosis (Cirrhosis) 11/2012 - 03/2011
2	Prescription Drug Overuse 06/2011 - 01/2007
2	Shock 12/2006 - 11/2005
2	Ischemia 11/2005 - 02/2004
1	Post-Acute COVID-19 Syndrome 12/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Lymphoma (Lymphomas) 01/2022
1	Aneuploidy (Aneuploid) 10/2021
1	Cognitive Dysfunction 03/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Dizziness (Lightheadedness) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021

Drug/Important Bio-Agent (IBA)

9	Analgesics (Analgesic Drugs)IBA 10/2021 - 08/2004
6	Tryptamines (Triptans)IBA 09/2016 - 05/2008
5	Monoclonal AntibodiesIBA 01/2024 - 11/2020
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2015
5	Proteins (Proteins, Gene)FDA Link 04/2021 - 11/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2008
4	Tyrosine Kinase InhibitorsIBA 01/2023 - 06/2013
3	Imatinib Mesylate (Gleevec)FDA Link 12/2023 - 08/2016
3	AntigensIBA 01/2022 - 12/2015
3	Pregnanolone (Allopregnanolone)IBA 11/2021 - 10/2020
3	Hormones (Hormone)IBA 03/2021 - 11/2005
3	AntibodiesIBA 11/2020 - 01/2012
3	Phosphotransferases (Kinase)IBA 01/2018 - 03/2015
3	Antidepressive Agents (Antidepressants)IBA 01/2018 - 12/2006
3	Topiramate (Topamax)FDA LinkGeneric 02/2017 - 01/2009
3	Sumatriptan (Imigran)FDA LinkGeneric 05/2008 - 08/2004
2	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 04/2022 - 10/2021
2	pregnenolone sulfateIBA 11/2021 - 03/2021
2	NeurosteroidsIBA 11/2021 - 03/2021
2	ProteomeIBA 04/2021 - 05/2020
2	nutlin 3IBA 04/2021 - 01/2016
2	Prostate-Specific Antigen (Semenogelase)IBA 11/2020 - 07/2017
2	Citalopram FDA LinkGeneric 02/2017 - 01/2009
2	Dasatinib (BMS 354825)FDA Link 08/2016 - 06/2013
2	Suppositories (Vaginal Suppositories)IBA 11/2015 - 08/2006
2	Caffeine (No Doz)FDA LinkGeneric 11/2015 - 08/2006
2	Docetaxel (Taxotere)FDA Link 09/2015 - 09/2013
2	Anticonvulsants (Antiepileptic Drugs)IBA 09/2011 - 12/2006
2	AndrogensIBA 07/2011 - 04/2009
2	Serotonin (5 Hydroxytryptamine)IBA 05/2008 - 12/2006
2	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2006 - 02/2006
2	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 02/2004 - 10/2003
1	Immunoglobulin G (IgG)IBA 01/2024
1	casirivimab and imdevimab drug combinationIBA 01/2024
1	GlucocorticoidsIBA 12/2023
1	AnthracyclinesIBA 01/2023
1	VaccinesIBA 01/2023
1	mirdametinibIBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	remdesivirIBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	molnupiravirIBA 01/2023
1	venetoclaxIBA 01/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2023
1	atogepantIBA 04/2022
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 04/2022
1	Calcitonin Gene-Related PeptideIBA 04/2022
1	CannabinoidsIBA 01/2022
1	Dehydroepiandrosterone (DHEA)IBA 11/2021
1	Dehydroepiandrosterone SulfateIBA 11/2021
1	PregnenoloneIBA 11/2021
1	CohesinsIBA 10/2021
1	erenumabIBA 10/2021
1	ChromatinIBA 10/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 03/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2021
1	lasmiditanIBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2009
4	Castration 11/2020 - 09/2013
3	Drug Therapy (Chemotherapy) 01/2018 - 01/2015
2	Artificial Respiration (Mechanical Ventilation) 01/2024 - 01/2021
1	Neoadjuvant Therapy 01/2023
1	Duration of Therapy 04/2022